MEDTRONIC PLC (MDT)

Here's Why Medtronic (MDT) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

3 Dividend Stocks I'll Never Sell

Micron Technology Moves Up In Market Cap Rank, Passing Medtronic

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:CLOV) EQNX::TICKER_END

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance for its...

Medtronic (MDT) Q2 2025 Earnings Call Transcript

MDT earnings call for the period ending September 30, 2024.

What's going on in today's session: S&P500 movers

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.

Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View

MDT delivers diversified growth across all its segments in the second quarter of fiscal 2025.

Compared to Estimates, Medtronic (MDT) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended October 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Medtronic Beats And Raises, But Shares Flirt With A Sell Zone

Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in premarket trading.

Medtronic revenue climbs 5%, more than analysts expected

Medtronic (MDT) Surpasses Q2 Earnings and Revenue Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 1.61% and 1.75%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?

Medtronic reports second quarter fiscal 2025 financial results

/PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October 25,...

Notable Monday Option Activity: MDT, CLW, GLNG

Jim Cramer's week ahead: Earnings from Nvidia, TJX and Walmart

CNBC's Jim Cramer previews key earnings reports and investor days that could trigger Wall Street action for the week of November 18.

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

The latest trading day saw Medtronic (MDT) settling at $87.53, representing a +1.78% change from its previous close.

Insights Into Medtronic (MDT) Q2: Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Medtronic (MDT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2024.

Beverly Hills surgeon sues Medtronic for patent infringement

The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against Medtronic.

MDT December 27th Options Begin Trading

Medtronic to announce financial results for its second quarter of fiscal year 2025

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second...